The need for skin pen marking for sentinel lymph node biopsy: A comparative study

Iranian Journal of Nuclear Medicine

Volumn 16, Issue 30, 2008, Pages 23-27

  Sadeghi, Ramin ^a   Forghani, Mohammad Naser ^b   Zakavi, Seyed Rasoul ^a   Jangjoo, Ali ^a   Shabani, Gholam Ali ^c   Kakhki, Vahid Reza Dabbagh ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ATOMIC ENERGY ORGANIZATION OF IRAN   (Iran)

Author keywords

Lymphoscintigraphy; Sentinel lymph node; Skin marking; Tc 99m antimony sulfide colloid

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M; DISULFINE BLUE; INK;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; LYMPH NODE DISSECTION; NEEDLE BIOPSY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SKIN; TUMOR VOLUME;

EID: 66749096080     PISSN: 16812824     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008; 247(2):207-213.
2. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006; 98(9):599-609. (Pubitemid 43904843)
3. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T et al. Technical outcomes of sentinel lymph node resection and conventional axillary lymph node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8(10):881-888. (Pubitemid 47488052)
4. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349(6):546-553. (Pubitemid 36951366)
5. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 2005; 23(19):4312-4321. (Pubitemid 46209968)
6. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 2005; 35(2):116-128. (Pubitemid 40568744)
7. Zanzonico P, Heller S. The intraoperative gamma probe: basic principles and choices available. Semin Nucl Med 2000; 30(1):33-48. (Pubitemid 30059088)
8. Bostick PJ, Giuliano AE. Vital dyes in sentinel node localization. Semin Nucl Med 2000; 30(1):18-24. (Pubitemid 30059086)
9. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223(2):217-224. (Pubitemid 26065217)
10. Thompson JF, Uren RF, Shaw HM, McCarthy WH, Quinn MJ, O'Brien CJ et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 1999; 189(2):195-204. (Pubitemid 29364693)
11. Tanis PJ, Valdés Olmos RA, Muller SH, Nieweg OE et al. Lymphatic mapping in patients with breast carcinoma: reproducibility of lymphoscintigraphic results. Radiology 2003; 228(2):546-551. (Pubitemid 36910100)
12. McMasters KM, Wong SL, Tuttle TM, Carlson DJ, Brown CM, Dirk Noyes R et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000; 231(5):724-731. (Pubitemid 30249834)
13. Tuthill LL, Reynolds HE, Goulet RJ Jr. Biopsy of sentinel lymph nodes guided by lymphoscintigraphic mapping in patients with breast cancer. Am J Roentgenol 2001; 176(2):407-411. (Pubitemid 32105649)
14. Buscombe J, Paganelli G, Burak ZE, Waddington W, Maublant J, Prats E et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging 2007; 34(12):2154-2159. (Pubitemid 350212147)
15. Laasanen MS, Heikkinen JO, Saarakkala S, Paajanen H. Localization of sentinel nodes in breast cancer: novel method and device to help pen marking of active nodes during gamma camera imaging. Phys Med Biol 2005; 50(7):49-54. (Pubitemid 40524548)
16. 99mTc-Antimony Sulfide Colloid for lymphoscintigraphy. Iran J Nucl Med 2003; 19:65-157
17. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186(3):275-283. (Pubitemid 28124433)
18. Reintgen D, Cox C, Haddad F, Costello D, Berman C. The role of lymphoscintigraphy in lymphatic mapping for melanoma and breast cancer. J Nucl Med 1998 Dec;39(12):22N, 25N, 32N, 36N.
19. Goyal A, Mansel RE. Does imaging in sentinel node scintigraphic localization add value to the procedure in patients with breast cancer? Nucl Med Commun 2005; 26(10):845-847.
20. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999; 91(4):368-373. (Pubitemid 29102337)
21. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36(10):1775-1780.
22. Valdés Olmos RA, Hoefnagel CA, Nieweg OE, Jansen L, Rutgers EJ, Borger J et al. Lymphoscintigraphy in oncology: a rediscovered challenge. Eur J Nucl Med 1999; 26(4 suppl):S2-S10. (Pubitemid 29171612)
23. Fleming FJ, Hill AD, Kavanagh D, Quinn C, O'Doherty A, Collins CD et al. Intradermal radioisotope injection optimises sentinel lymph node identification in breast cancer. Eur J Surg Oncol 2003; 29(10):835-838. (Pubitemid 37493279)